Developmental therapeutics is clinical research aimed at finding new and innovative anti-cancer therapies. It includes the exploration of new drugs, new combinations of drugs, new technologies, and new cell and immune therapies for cancer treatment. Once identified, these new therapies are tested in patients for safety, appropriate dosing and efficacy within the confines of a clinical trial. The ultimate goal of developmental therapeutics work is to identify novel therapies that are safe and effective in treating children with cancer while also preserving their quality of life.
We’re committed to finding innovative treatments for children with cancer and blood disorders.
As Georgia’s top pediatric cancer research center, we are committed to excellence and innovation in pediatric cancer and blood disorders research.Read More
- We are proud to provide numerous unique local trials developed and led by our very own clinical research team members. These include trials treating children with a variety of recurrent and high-risk cancers.
- We are a member of the Children’s Oncology Group (COG) Pediatric Early Phase-Clinical Trial Network (PEP-CTN)—one of only 21 centers nationwide. This prestigious membership allows us to offer novel and innovative therapies to children and young adults with a wide range of cancer diagnoses.
- We are one of 11 national members of the Pediatric Brain Tumor Consortium (PBTC), a multidisciplinary cooperative research organization dedicated to providing new and innovative therapies to children with recurrent or progressive high-risk brain tumors.
- We are a member of the New Approaches to Neuroblastoma Therapy (NANT), a consortium dedicated to developing new therapies specifically for children with neuroblastoma that improve outcomes and minimize side effects.
- We are a member of Therapeutic Advances in Childhood Leukemia (TACL), a consortium dedicated to developing innovative therapies for incurable leukemia and lymphoma.
- The developmental therapeutics team partners with our blood and marrow transplant (BMT) team to provide patients with new and innovative cellular therapies.
- The Aflac Cancer and Blood Disorders Center has dedicated providers who specialize in palliative care to help support our developmental therapeutics patients and their families.
Receiving a cancer diagnosis for your child can be an emotional and overwhelming experience. At the Aflac Cancer and Blood Disorders Center, we are here to support you and your family. We make it our mission to provide the best care—and best experience—for every child, whether treating a toddler during an emergency or helping a teen through chemotherapy treatments. Family plays an important role in your child’s well-being. Not only are you a vital part of your child’s healthcare team; you are a source of security and comfort.
The Future of Pediatric Cancer and Blood Disorders Care
Our Future State-of-the-Art Campus
The North Druid Hills campus is designed to improve outcomes, help deliver cutting-edge care and bring lifesaving medical research directly to patients.SEE WHAT'S IN STORE
Developmental therapeutics physicians
- Jason Fangusaro, MD, Program Director, Neuro-Oncology
- Tobey MacDonald, MD, Neuro-Oncology
- Dolly Aguilera, MD, Neuro-Oncology
- R. Craig Castellino, MD, Neuro-Oncology
- Thomas Cash, MD, MSc, Solid Tumor
- Kelly C. Goldsmith, MD, Solid Tumor
- Melinda Pauly, MD, Leukemia and Lymphoma
- Himalee Sabnis, MD, Leukemia and Lymphoma
Advanced practice providers
Patient care navigator
- Kate Glasscox, BSN, RN, CPN
- Amy Autry-Bush, BS, CCRP, Lead Research Coordinator
- Melissa Schink, MSN, RN
- Olivia Floyd, BSN, RN
- Christie Frick, BSN, RN, CPN
- Amber Kaminski, MSN, RN
- Bailey Sturdivant, BS, CRC
Solid tumor and MIBG clinical nurse coordinator
- Sarah Carlin, BSN, RN, CPHON